Recently, TSPO has attracted attention as a possible molecular target for tumor imaging and chemotherapy (Austin et al., 2013), and initial clinical trials have indicated that TSPO ligands might be valuable in the treatment of neurological and psychiatric disorders (Rupprecht et al., 2010). The gene discussed is TSPO; the disease is psychiatric disorder.